Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Researchers at the University of North Carolina found that a once-weekly injection of Ozempic could cut cravings at its ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

When you buy through links on our articles, Future and its syndication partners may earn a commission.

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank ...

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA ...